
This landmark trial could lead to a significant step forward in the early detection of breast cancer, offering women faster, more accurate diagnoses when it matters most.
Professor Lucy Chappell, chief executive of the National Institute for Health and Care Research, the organization that is funding an £11m study to use artificial intelligence to analyze mammograms.
Why It Matters: Several major organizations in the U.K. are launching research on the use of AI in breast cancer detection, aiming to help more than 2 million women who battle the disease each year.
What To Know:
- The U.K.’s National Health Service is launching the world’s largest trial using AI to help radiologists detect breast cancer more quickly. Five types of AI will analyze approximately half of the mammograms conducted at 30 breast cancer screening centers across England. The remaining scans will be assessed by human radiologists to compare AI accuracy against traditional methods.
- At the France AI Action Summit, Google announced a partnership with the Institute of Women’s Cancers with a focus on using AI to predict a cancer’s risk of reoccurance and map individualized treatment options for patients.
- A previous study exploring AI use in breast cancer detection in Sweden in 2023, with a smaller sample size, confirmed that AI does not lead to an increase in false positives.
If successful, AI could replace the current two-radiologist system, allowing one radiologist to review scans with AI providing a second analysis. This could free up specialists, improve accuracy and reduce wait times for results.
Read More: NHS Launches World’s Biggest Trial Of AI Breast Cancer Diagnosis (The Guardian)
Google Partners With Institute of Women’s Cancers In AI Research (Google)
Nationwide real-world implementation of AI for cancer detection in population-based mammography screening (Nature Medicine)
Image Credit: Adobe Stock / Okrasiuk
by Jalen Meyerpeter, Based in Arizona.




